Massive haemorrhage protocol originated in bloodless care, but is now being applied to all patients instead of massive transfusion protocol, because of adverse outcomes and lack of efficacy of allogeneic blood products. Erin Suydam, MD, explains the use of massive haemorrhage protocol in bloodless care and the general application to all patients in patient blood management.
Dr. Suydam is a Trauma/Acute Care/Surgical Critical Care attending surgeon at Allegheny Health Network in Pittsburgh, PA, USA. She is also the Medical Director of the Patient Blood Management and Bloodless Medicine program at Allegheny Health Network. Dr Suydam is Assistant Professor, Department of Surgery, Drexel University College of Medicine and Medical Student Surgical Clerkship Co-Director. She trained in General Surgery at the Medical College of Georgia in Augusta, GA and in Surgical Critical Care at the University of Hawaii in Honolulu, HI. She has been in practice for ten years.
